Skip to main content
. 2020 Aug 7;7(9):1557–1563. doi: 10.1002/acn3.51139

Table 1.

Demographic and clinical data

Variable Summary (N=855)
Age at PD onset (years) 64 (22, 94)
Sex (male) 548 (64.1%)
Initial visit
Age (years) 69 (28, 97)
Disease duration (years) 3 (0, 38)
Medication includes levodopa 394 (46.1%)
Good levodopa responsivity 362 (91.9%)
Bradykinesia 818 (95.7%)
Rigidity 819 (95.8%)
Postural instability 181 (21.1%)
Resting tremor 590 (69.0%)
Postural tremor 199 (23.3%)
Kinetic tremor 61 (7.1%)
Dementia 4 (0.5%)
Dystonia 83 (9.7%)
Dyskinesia 87 (10.2%)
Autonomic dysfunction (GI, UG) 519 (60.7%)
Impulse control disorder 9 (1.1%)
(Pseudo‐)hallucinations 43 (5.0%)
Depression 261 (30.5%)
Orthostatic hypotension 61 (7.1%)
REM sleep behavior disorder (RBD) 91 (10.6%)
Restless legs syndrome (RLS) 42 (4.9%)
Most recent visit
Age (years) 72 (28, 98)
Disease duration (years) 6 (0, 48)
Medication includes levodopa 681 (79.6%)
Good levodopa responsivity 656 (96.3%)
Bradykinesia 834 (97.5%)
Rigidity 828 (96.8%)
Postural instability 265 (31.0%)
Resting tremor 545 (63.7%)
Postural tremor 106 (12.4%)
Kinetic tremor 34 (4.0%)
Dementia 62 (7.3%)
Dystonia 116 (13.6%)
Dyskinesia 194 (22.7%)
Autonomic dysfunction (GI, UG) 626 (73.2%)
Orthostatic hypotension 118 (13.8%)
Impulse control disorder 16 (1.9%)
(Pseudo‐)hallucinations 107 (12.5%)
Depression 308 (36.0%)
REM sleep behavior disorder (RBD) 104 (12.2%)
Restless legs syndrome (RLS) 55 (6.4%)
Survival information
Death 316 (37.7%)
Follow‐up length after PD onset (years) 8 (1, 48)
PD subtype
TD 371 (43.4%)
AR 241 (28.2%)
GD 88 (10.3%)
Mixed 155 (18.1%)
Rapid progression 262 (41.4%)
Dementia within 5 year of onset 35 (6.3%)
Falling within 5 years of onset 231 (37.0%)
Become dependent on a caregiver within 5 years of onset 51 (9.0%)

TD, tremor dominant; AR, akinetic‐rigid; GD, Gait difficulty; GI, gastrointestinal; UG, urogenital.

The sample median (minimum, maximum) is given for continuous variables. Information was available regarding rapid progression for n = 633 patients; information on dementia within 5 years of PD onset was available for n = 557, on falling within 5 years of PD onset for n = 625, and on becoming dependent on another person within 5 years of PD onset for n = 566 patients. Information on rapid progression was unavailable for n = 222 patients due to the combination of absence of these three characteristics and insufficient follow‐up length. Survival information was available for n = 838 patients.